Bioactive Halogenated Metabolites of Marine Organism
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (15 September 2021) | Viewed by 304
Special Issue Editors
Interests: Structure Elucidation; Natural Product Chemistry; NMR Structure Elucidation; Natural Product Isolation
Interests: marine natural products; marine toxins; marine polyether; marine microalgae; biosynthesis; Laurencia; antiparasitic substances; phosphatase inhibitors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bioactive halogenated metabolites from marine organisms continue to be a prolific source of new structure and biologically active molecules. For that reason, this group of secondary metabolites continues to be the subject of much attention in specialized groups of marine chemistry and biology for both the discovery of new bioactive marine natural products and their mode of interaction with biomolecules. Although, initially, these types of metabolites were present mainly in red algae, lately, more and more of them are found in various marine organisms, including cyanobacteria, fungi, sponges, etc. Accordingly, the aim of this Marine Drugs Special Issue is to cover new findings on the potential therapeutic activity of halogenated molecules obtained from marine sources as well as those related produced by synthesis, highlighting novel structural features, bioactivities, and mechanisms of action. Review articles that make substantial advances within this field will also be considered.
As Guest Editors of this Special Issue of Marine Drugs, we encourage scientists working in any field involving new natural molecules with biological activities or industrial applications to contribute to recent research that may lead to significant advances in the area.
Dr. Manuel Norte
Prof. Dr. José Javier Fernández Castro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Halogenated metabolites
- Biological applicatons
- Synthesis
- Mechanisms of action
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
